Healthcare Asia Summit 2023

Alex Boulton is a partner in our Private Equity and Healthcare & Life Sciences practices, based in our Singapore office.

He leads our Healthcare and Life Sciences practice for Southeast Asia and, since joining Bain in 2010, Alex has led numerous strategy and transformation programs with healthcare companies across the region and value chain; covering payers, providers, pharma, MedTech and digital health. In addition, he leads the Healthcare sector for our APAC private equity practice, supporting healthcare commercial due-diligence, portfolio, and fund strategy engagements.

He holds a BSc in Economics, with First-Class Honours, from the London School of Economics and Political Science.

David Boucher has worked in healthcare for over 40 years, the last two years as Chief of Service Excellence with Dubai-based Aster DM Healthcare.  Prior to that David served as Chief Business Transformation Officer at Bumrungrad International Hospital in Bangkok, Thailand.  Between 2000 and 2017, he served as an executive of BlueCross of South Carolina. From 2012-2017, David served as President of UCI Medical Affiliates in Columbia, SC.  In that capacity, he managed 80 retail medical care centers- treating over 740,000 patients in 2017.  From 2006 through 2016, Mr. Boucher also served as President of Companion Global Healthcare, Inc. – the world’s only medical tourism facilitator owned by a major health insurer.  Prior to 2000, David served as CEO at several hospitals in the U.S.

Mr. Boucher earned his BS degree from Slippery Rock University (PA) and a MPH from the University of South Carolina; he has been named a distinguished alumnus by both institutions.

David has been quoted in over 250 newspapers and journals including The Wall Street Journal, New York Times, The Economist, U.S. News & World Reports. He has been interviewed on NBC Nightly News and Fox Business News.  He as delivered lectures on disruptive innovation in healthcare at Harvard Business School, Yale School of Management, and Harvard Medical School.

Dr. Walter has twenty years of experience in the Singapore and Asia-pacific healthcare markets.

In his role as the Singapore Managing Director at Fullerton Health, Dr. Walter leads health tech initiatives in Singapore including telemedicine and healthcare analytics. He also oversees Clinical Services in Singapore including primary care, allied health, pharmacy, and ambulance services.

He has led multiple COVID-19 response projects with the Ministry of Health, Ministry of Manpower, and driven the integration of wellness, health screening, and primary care services to form Fullerton Health Singapore's Primary & Preventive Care Division.

He was previously Managing Director at Integrated Health Plans (IHP) overseeing corporate health business lines for its group insurance and employer benefits client base in Singapore and Malaysia.

In his earlier career, he served as an investment professional in a corporate venture capital fund linked to Singapore's Economic Development Board and was part of the team during the establishment of Singapore’s National Electronic Health Record. He also practiced as a physician at Singapore General Hospital and various SingHealth group institutions.

Tullawat Pacharapha, M.D., Ph.D.

Tullawat is the chief operating officer at Vejthani hospital. He also serves as a member of the HIMSS APAC Advisory Board, the instructor for the College of Management Mahidol University, and a frequent speaker at healthcare management conferences. Tullawat holds the degree of Doctor of Medicine, Board of Orthopaedic Surgery, Master of Business Administration, and Doctor of Philosophy in Management.

Vejthani Hospital, established in 1994, is one of the leading private international hospitals in Thailand that provides JCI accredited quaternary health care services. Pursuing digital transformation, the hospital integrates digital technology into areas of its business resulting in how it delivers value to customers. The digital initiatives include CRM System to support the medical traveler care continuum, Business Intelligence to make informed decisions, Transportation Management System to optimize patient transportation services, Robotic Processing Automation to replace manual repetitive rules-based processes, and the new Hospital Information System, for delivering, managing, and transforming care.

Dr. Gunnaphon specializes in Family Medicine Profession, currently he works at Bangkok Hospital Rayong (BRH), member of BDMS, for 4 years. He has developed Predicting Center for mass NCD patients prediction and Academic Center to support the Center of Excellent (CoE) focusing on the area of trauma, cancer and occupational health. With his knowledge and capability, during Thailand pandemic he sucessfully operated "Telemedicine System" to monitor populous COVID-19 patients in hospitels, therefore, BRH nominated and later on appointed Dr. Gunnaphon as Chief of Wellness Center and Chief of Academic Center respectively.

Dr. Kelvin Tan is the current Head of Service of the Adult Reconstruction Service, and Senior Consultant at Dept of Orthopaedic Surgery, Tan Tock Seng Hospital. 

A Clinical Champion in TTSH Knee Replacement Clinical Pathway and anchor of the Enhanced Recovery After Surgery (ERAS) Knee Replacement Taskforce, he is a strong advocate for ERAS after knee replacements, putting in place various protocols to improve patient's outcomes after knee replacement surgeries while dramatically reducing length of hospital stay and successfully transiting TTSH Knee Replacement to Ambulatory Surgery

Dr. Kelvin holds academic positions with both Yong Loo Lin School of Medicine, National University of Singapore (NUS), and Lee Kong Chian School of Medicine, Nanyang Technological University (NTU). He is an Adjunct assistant Professor and Senior Clinical lecturer for NUS and also a Core Clinical Competencies Committee Faculty Member of the National Healthcare Group (NHG) Orthopaedic Residency program, mentoring the next generation of training Orthopaedic surgeons in Singapore.

Stella Ramette is Director, Customer Relations and Sales, South East Asia for InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems. Based in Singapore, Stella leads the company’s South East Asian operations, providing local resources to a growing customer base and ensuring that InterSystems is responsive to their needs.

Stella has over 20 years of experience spanning healthcare IT, diagnostics, medical imaging, and medical technology. She has held positions in management, sales, marketing, and product management for established multinational corporations including Philips, Atos Medical, and Qualcomm as well as start-up companies. For most of her career, Stella has been based in Sweden, with roles covering the Nordic territories. Prior to relocating to Singapore in the first half of 2021, she also worked on weekends as a volunteer COVID-19 Vaccination Nurse in Malmö. 

Stella studied to become a Registered Nurse, specializing in operating theatre nursing, at Malmö University. She also holds a Master of Science and Business Administration from Lund University School of Economics and Management.

Summary of relevant experience

• Deep pharmaceutical experience including R&D, and Commercial
• Pricing and innovative funding
• Digital and operating model transformation
• MedTech and BioTech experience

Profile summary

Partha is a Principal in the Singapore office and a core-team member of BCG's Health Care practice in Southeast Asia. He has 10+ years of experience in the industry and strategy consulting across diverse geographies including Asia Pacific, Middle East, Africa, and Emerging Markets

Prior to BCG, Partha was Director at EY-Parthenon, leading projects and business development for life sciences clients across ASEAN and broader APAC. He also worked with Deloitte Consulting, J&J Medical, and Pfizer India.

Partha holds an MBA from the Indian Institute of Management, Lucknow

Chris is a Partner at Pureland Venture, looking after value creation activities for post-investment scale-up of healthtech innovation companies.  In addition, Chris moreover serves in the KPMG Global Health Centre of Excellence and as a strategic advisor for policy dialogue at APACMed (with a particular focus in the digital health domain).  Chris holds additional healthcare ecosystem roles too ranging from public/private UHC design taskforces through to visiting lectureship at leading academic centres.  Chris is presently based in Singapore, having lived and worked around the globe; he is most passionate about bringing safe, effective, economically-viable medical innovations to those populations in need.

Abhay is an EY-Parthenon Partner in the Strategy and Transactions team at Ernst & Young Solutions LLP in Singapore. He is also EY Asean Life Sciences and Health Care Leader. Abhay primarily serves life sciences, health care, and private equity clients in Southeast Asia.

With wide-reaching experience, he focuses on advising clients on their transformation agenda; strategic planning efforts; overall portfolio strategy; and growth, market entry and acquisition strategies. He also advises clients on liquidity and working capital management, market attractiveness for new business ventures, initial public offering readiness, and post-merger integration and divestitures.

Prior to joining EY, Abhay worked with another professional services organization, leading its strategy and operations team for Southeast Asia.

He earned a bachelor’s degree in Accounting and Economics from St. Stephen’s College of Commerce and an MBA from National University of Singapore.

Mr Yong Yih Ming has almost two decades of healthcare experience as a business and operational leader with IHH Healthcare, one of the world’s largest healthcare networks with 82 hospitals in 10 countries, Raffles Medical Group (RMG), a leading integrated private healthcare provider in Asia, and Alexandra Hospital (AH), a Singapore tertiary hospital of the National University Health System.

He is the Chief Executive Officer of one of Singapore’s largest private tertiary and multispecialty healthcare facility at Mount Elizabeth Hospital (MEH). Prior to this, he was General Manager of Singapore’s largest private network of outpatient ambulatory facilities and was heading the Covid-19 projects at RMG. He had hospital development and operations experiences at AH.

As Chief Executive Officer of MEH, he is responsible for its financial targets, operational quality, and licensee obligations of the 345-bed JCI accredited tertiary hospital with a community of 600 doctors and 1,300 healthcare workers. He is a member of the Medical Advisory Board, MCST Council and is also responsible for the multi-year hospital redevelopment project – Project Renaissance.

At RMG, he was an EXCO member and GM of Raffles Medical. He was responsible for the financial targets, growing and managing RMG’s corporate businesses, the operational quality and licensee obligations of the 50 ambulatory, primary care and health screening facilities, including national Covid-19 projects. In 2010, he led a team to set up RMG’s flagship medical facility in Shanghai, China.

At AH, he managed ambulatory operations, operational support services and business development. He was a member of the Khoo Teck Puat Hospital Planning Committee that designed the hospital and chaired the Operational Support Services Workgroup.

He has guest lectured at the NUS Saw Swee Hock School of Public Health’s Master of Public Health programme since 2018 and holds an MBA in Healthcare Management from the NUS Business School. He was a member of the MOH Primary Care Network Council and volunteers as a District Councillor with the South East Community Development Council since 2011.

Num has extensive experience in clinical, operational, executive and strategic board roles in the health sector. He assists tertiary hospitals in improving the patient experience and service standards; procurement operations; cost management; business strategy and innovation; physician recruitment as well as quality assurance, improvement and accreditation.  
 
He also helps them to develop new clinical programs and services as well as assess and implement new technologies.  
Num was previously Group CEO of a leading hospital in Indonesia and the CEO of a major private health care facility in Thailand. He also practiced as a specialist rehabilitation physician in Australia’s and Thailand’s public and private sectors.  

Num is a Fellow of the Australasian Faculty of Rehabilitation Medicine, Royal Australasian College of Physicians. He holds an MBBS from the University of Melbourne, Australia, and an MSc in Management from Stanford University, US. 

Lim Wai Mun is the Founder & CEO of Doctor Anywhere, a regional tech-enabled healthcare company that provides telemedicine and a holistic range of health offerings.

While distributing lunchboxes to the elderly living in older housing estates in 2016, he saw how seniors lacked access to basic healthcare due to their inability to leave their homes. 

Moved by this experience, he founded Doctor Anywhere in 2017 with a vision to provide simple, accessible, and efficient healthcare for everyone. His experience in private equity and nearly a decade in Temasek Holdings, where he helped conceptualise and establish Pavilion Energy, a Singapore-based LNG company, enabled him to propel Doctor Anywhere’s growth from a young telehealth startup to a regional health player with 2.5 million users across 6 countries today.

Andrew joined Prudential Corporation Asia as Chief Health Officer in January 2018. Andrew has over 30 years of international experience in executive management positions across Asia, Australia, Middle East and Europe in the insurance and healthcare industry. Prior to joining PCA, Andrew was the CEO, Asia Pacific of Munich Health from 2014 to 2017, based in Singapore. Prior to that, Andrew held a number of senior executive positions within Bupa in Asia and the UK. The latest position he had with Bupa was the CEO of Bupa Thailand from 2008 to 2014. Andrew is a Chartered Accountant and he holds a Master of Commerce degree from the University of New South Wales, Australia.

2013–Present Chief Executive Officer -Non Hospital Group (7.1)
                        Bangkok Dusit Medical Service Public Co., Ltd.                                (BDMS)

• Management Board of Directors of BDMS
• Managing Director of N Health, a leading healthcare service solution provider supporting the medical laboratory diagnostic, supply chain management, infectious control and biomedical engineering for more than 700 leading hospitals as well as clinical research in Asia
• Managing Director of Bio Molecular Laboratories (Thailand) Co., Ltd.
• Managing Director of N Health Pathology Co., Ltd.
• Managing Director of N Health Myanmar Co., Ltd.
• Managing Director of N Health (Cambodia) Co., Ltd.
• Managing Director ofN Health Novogene Genomics Co., Ltd.
• Member of the Board of Directorsof Bangkok Hospital Hatyai
• Member of the Board of DirectorsofGeneral Hospital Products Plc.

2004-2007 Regional Operations Director based in Singapore
                  TNT Express Worldwide 

Additional roles and social activities;

• Academic Committee for Biomedical Engineering Major ofScience Faculty of Rangsit University
• Honorable lecturer at Ramathibodi medical school of nursing
• Honorable lecturer of MBA program of Chulalongkorn University
• Guest lecturer at schools, universities, and various associations for the topic of healthcare and healthcare supply chain management

Serene is the co-founder of Speedoc, one of the region's leading digital health startups. In 2020, Speedoc raised S$6.7 million in a Series A funding round led by Vertex Ventures; and in 2022, raised a further S$28 million in a pre-Series B funding to expand its virtual hospital programme.

During the pandemic, Speedoc was a key member in Singapore’s COVID-19 response providing telemedicine services, administering COVID-19 vaccinations and other nursing services to the housebound. As part of the efforts to uplift the healthcare landscape, Serene also worked with government and hospital partners to pilot and create the Hospital@Home virtual hospital service in Singapore. Speedoc has since discharged more than 4,000 patients successfully from its virtual hospital programme. Today, Serene leads a team of 200 in 3 countries and works on establishing Singapore’s digital health leadership in the region, with close to 200, 000 patients who have used Speedoc's services till date.

Stephen has 21 years of experience as a strategic advisor in Asia and Europe; he leads L.E.K.’s Healthcare and Life Science in SE Asia, based in Singapore.

He advises on organic growth investments as well as partnering and M&A situations, working with some of the largest and most complex multinational healthcare organizations in the world, publicly traded organizations and private equity investors, governments, industry advocacy bodies, and innovative startups.

His experience in healthcare spans international growth, business planning and opportunity evaluation, market access, as well as connected care and Healthcare IT.

Stephen joined L.E.K. in Europe and has supported L.E.K.’s growth in Asia since 2005. He holds a Master’s in Manufacturing Engineering from the University of Cambridge.

Arnaud Bauer, a Partner in L.E.K. Consulting’s Singapore office, is the Head of Healthcare Services and Healthcare M&A for Southeast Asia. He has over 15 years of experience in strategy consulting in healthcare and private equity, advising investors, healthcare providers, and government agencies. His experience in the healthcare provider space spans the entire care continuum, including primary care, telehealth, multispecialty hospitals, IVF, long-term care, laboratories, mental health, and cosmetic centers, as well as with government agencies for healthcare investment planning and promotion across the Middle East and Asia-Pacific regions. 

Prior to joining L.E.K., Arnaud was an Associate Principal at IQVIA in Singapore and Managing Director for a strategy consulting boutique in Dubai. He holds a Master of Engineering from École Centrale and a Master of Business from ESSEC Business School in partnership with Nanyang Technological University, Singapore.